Portfolio Manager Factsheet

August 2018

Momentum seen in July carried over again into August as fund flows continued to find their way into the healthcare space. Alexion Pharmaceuticals traded lower after a competitor announced a phase-up in the development of a rival drug to treat rare blood disorders. 

Read more »

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.